Predictions
Fresenius Medical Care AG & Co KGaA ADR
Start price
Target price
Perf. (%)
€17.20
06.04.24
06.04.24
-
06.04.25
06.04.25
11.63%
25.04.24
25.04.24
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€25.07
04.04.24
04.04.24
-
04.04.25
04.04.25
9.01%
26.04.24
26.04.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.05
03.02.24
03.02.24
-
03.02.25
03.02.25
1.90%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Fresenius Medical Care AG & Co KGaA ADR
Start price
Target price
Perf. (%)
€18.50
08.01.24
08.01.24
-
08.01.25
08.01.25
3.78%
25.04.24
25.04.24
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€44.00
03.01.24
03.01.24
-
03.01.25
03.01.25
-1.59%
26.04.24
26.04.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Fresenius Medical Care AG & Co KGaA ADR
Start price
Target price
Perf. (%)
€17.70
17.11.23
17.11.23
-
17.11.24
17.11.24
8.47%
25.04.24
25.04.24
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€53.60
14.11.23
14.11.23
-
14.11.24
14.11.24
-10.73%
31.01.24
31.01.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.00
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€24.38
31.10.23
31.10.23
-
31.10.24
31.10.24
12.10%
26.04.24
26.04.24
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€33.12
11.10.23
11.10.23
-
11.10.24
11.10.24
14.79%
12.12.23
12.12.23
Known brand
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€38.99
04.10.23
04.10.23
€22.00
04.10.24
04.10.24
-16.75%
14.10.23
14.10.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Vita 34 AG
Start price
Target price
Perf. (%)
€4.76
19.09.23
19.09.23
€6.00
19.09.24
19.09.24
-1.68%
30.09.23
30.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Vita 34 AG
Start price
Target price
Perf. (%)
€4.79
07.09.23
07.09.23
-
07.09.24
07.09.24
-4.59%
16.09.23
16.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€46.77
08.08.23
08.08.23
-
08.08.24
08.08.24
-23.22%
31.01.24
31.01.24
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€48.33
27.07.23
27.07.23
€57.00
27.07.24
27.07.24
-22.26%
26.04.24
26.04.24
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected